Alexander (Sasha) Kamb is the senior vice president for research at Amgen. Dr. Kamb received his A.B. from Harvard University and his Ph.D. from Caltech. After a postdoctoral fellowship at UCSF, he worked in the biotechnology field for about ten years, specializing in the genetics of cancer, and then in the Pharmaceutical sector where he led the Novartis Oncology Research Group. In 2006, Dr. Kamb joined Amgen to direct Oncology Research at their South San Francisco site. In 2007 he took over the leadership of the Neurosciences Therapeutic Area. In February 2010 he was promoted to Vice President, Research, Neuroscience, and was given the remit to build a specialized department within Amgen Research (Genome Analysis Unit) focused on cross-disease-area applications of next-generation sequencing. At the end of 2011, Dr. Kamb was promoted to Senior Vice President to head all of Amgen’s discovery research.